These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 9602212)

  • 21. A report of a case with pure red cell aplasia induced by sodium valproate.
    Kawauchi K; Miyano T; Ikeda Y; Tateoka N; Kasai M; Sato Y; Yokoyama M
    Acta Paediatr Jpn; 1989 Oct; 31(5):615-9. PubMed ID: 2515743
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hypersensitivity syndrome and pure red cell aplasia following allopurinol therapy in a patient with chronic kidney disease.
    Chao SC; Yang CC; Lee JY
    Ann Pharmacother; 2005 Sep; 39(9):1552-6. PubMed ID: 16076905
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epoetin-induced pure red cell aplasia successfully treated with androgens.
    Sánchez de la Nieta MD; Caparrós G; Rivera F
    J Nephrol; 2006; 19(2):220-1. PubMed ID: 16736425
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Successful treatment of tacrolimus-related pure red cell aplasia and autoimmune hemolytic anemia with rituximab in a pediatric cardiac transplant patient.
    Abongwa C; Abusin G; El-Sheikh A
    Pediatr Blood Cancer; 2017 Dec; 64(12):. PubMed ID: 28598573
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [A case of pure red cell aplasia associated with sodium valproate therapy].
    Anzai K; Kitajima H; Kubo M
    Rinsho Ketsueki; 1994 Mar; 35(3):286-90. PubMed ID: 8158850
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pembrolizumab-induced Pure Red Cell Aplasia Successfully Treated with Intravenous Immunoglobulin.
    Isoda A; Miyazawa Y; Tahara K; Mihara M; Saito A; Matsumoto M; Sawamura M
    Intern Med; 2020 Aug; 59(16):2041-2045. PubMed ID: 32389947
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epoetin-induced pure red-cell aplasia (PRCA): preliminary results from the research on adverse drug events and reports (RADAR) group.
    Evens AM; Bennett CL; Luminari S
    Best Pract Res Clin Haematol; 2005; 18(3):481-9. PubMed ID: 15792923
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A clinical review of antibody-mediated pure red cell aplasia.
    Vogel S; Rossert J
    Nephrol Nurs J; 2005; 32(1):17-8, 23-6; quiz 27. PubMed ID: 15787081
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pure red cell aplasia in a prostate cancer patient treated with leuprolide acetate and chlormadinone acetate.
    Kobayashi M; Nukui A; Morita T
    Int J Urol; 2005 Nov; 12(11):1010-1. PubMed ID: 16351663
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Pure red cell aplasia in erythropoietin therapy in patients with kidney failure].
    Opatrný K
    Cas Lek Cesk; 2003; 142(12):741-5. PubMed ID: 14746223
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pure red cell aplasia due to treatment with epoietin beta: first case report of PRCA from Poland.
    Sułowicz W; Bentkowski W; Stompór T; Gross J; Biłyk A; Rudzki Z
    Przegl Lek; 2006; 63(9):810-4. PubMed ID: 17479877
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pure red cell aplasia induced by anti-erythropoietin antibodies, well-controlled with tacrolimus.
    Hashimoto K; Harada M; Kamijo Y
    Int J Hematol; 2016 Oct; 104(4):502-5. PubMed ID: 27338269
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reversible pure red cell aplasia associated with diphenylhydantoin therapy.
    Kueh YK; Yeo TC; Choo MH
    Ann Acad Med Singap; 1991 May; 20(3):407-9. PubMed ID: 1929190
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinico-haematological profile of pure red cell aplasia in children.
    Marwaha RK; Bansal D; Trehan A; Marwaha N; Varma N
    J Trop Pediatr; 2002 Apr; 48(2):113-6. PubMed ID: 12022425
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Acquired pure red cell aplasia in a patient with B cell chronic lymphocytic leukemia after fludarabine therapy].
    Tsuji T; Hirano T; Yamasaki H; Tuda H
    Rinsho Ketsueki; 2015 Jun; 56(6):705-10. PubMed ID: 26256883
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical characteristics of erythropoietin-associated pure red cell aplasia.
    Carson KR; Evens AM; Bennett CL; Luminari S
    Best Pract Res Clin Haematol; 2005; 18(3):467-72. PubMed ID: 15792921
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Isoniazid-induced pure red cell aplasia.
    Hoffman R; McPhedran P; Benz EJ; Duffy TP
    Am J Med Sci; 1983; 286(1):2-9. PubMed ID: 6869413
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Pure red cell aplasia in patient affected by myelodysplastic syndrome treated with R-Epo].
    Luraschi A; Montanara S; Fedeli P; Buscaglia P; Fossati O; Cozzi S; Castello A
    Recenti Prog Med; 2008 May; 99(5):255-7. PubMed ID: 18581968
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recommendations on haematological criteria for the diagnosis of epoetin-induced pure red cell aplasia.
    Casadevall N; Cournoyer D; Marsh J; Messner H; Pallister C; Parker-Williams J; Rossert J
    Eur J Haematol; 2004 Dec; 73(6):389-96. PubMed ID: 15522059
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antibody-mediated pure red cell aplasia due to epoetin alfa during antiviral therapy of chronic hepatitis C.
    Stravitz RT; Chung H; Sterling RK; Luketic VA; Sanyal AJ; Price AS; Purrington A; Shiffman ML
    Am J Gastroenterol; 2005 Jun; 100(6):1415-9. PubMed ID: 15929778
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.